Outstanding post, Guadisso. I hope when the quiet period is over that Omeros makes the pre-IPO video or an equivalent video available. I've been happily buying OMER in this post-IPO SP "canyon". OMER has a terrific pipeline of both drugs and processes.
Just to clarify Omeros becomes marginable on Monday, Nov. 9th and the quiet period ends Monday, Nov. 16th. For those interested here's a technical review article explaining what's the big deal about orphan GPCRs of which Omeros possesses around 65. A single GPCR recently was licensed for $200 million by Norvartis.